| Title |
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
|
|---|---|
| Published in |
Trials, May 2020
|
| DOI | 10.1186/s13063-020-04352-9 |
| Pubmed ID | |
| Authors |
Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Yi Hu, Zhenshun Cheng, Ling Gao, Yang Jin, Guangwei Luo, Shouzhi Fu, Qiaofa Lu, Guanhua Du, Ke Wang, Yang Lu, Guohui Fan, Yi Zhang, Ying Liu, Shunan Ruan, Wen Liu, Thomas Jaki, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 293 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 293 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 47 | 16% |
| Student > Bachelor | 42 | 14% |
| Researcher | 24 | 8% |
| Other | 18 | 6% |
| Student > Ph. D. Student | 18 | 6% |
| Other | 46 | 16% |
| Unknown | 98 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 74 | 25% |
| Nursing and Health Professions | 21 | 7% |
| Biochemistry, Genetics and Molecular Biology | 16 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 5% |
| Agricultural and Biological Sciences | 8 | 3% |
| Other | 51 | 17% |
| Unknown | 107 | 37% |